The occurrence of mutant KRAS clones in the blood of RAS wild type colorectal cancer patients - impact of response or failure under anti-EGFR therapy

被引：0
|
作者：
Berger, A. W. [1 ]
Schwerdel, D. [1 ]
Welz, H. [1 ]
Moeller, P. [2 ]
Ettrich, T. J. [1 ]
Seufferlein, T. [1 ]
机构：
[1] Univ Ulm Klinikum, Klin Innere Med 1, Ulm, Germany
[2] Univ Ulm Klinikum, Inst Pathol, Ulm, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2016年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
0514
引用
收藏
页码：14 / 14
页数：1
相关论文
共 50 条
  • [41] KRAS Mutation Testing of Colorectal Cancer for Anti-EGFR Therapy: Dogmas Versus Evidence
    Timar, J.
    Hegedus, B.
    Raso, E.
    CURRENT CANCER DRUG TARGETS, 2010, 10 (08) : 813 - 823
  • [42] BRAF mutation predicts resistance to anti-EGFR monoclonal antibodies in wild-type KRAS metastatic colorectal cancer
    Chen Mao
    Ru-Yan Liao
    Qing Chen
    Journal of Cancer Research and Clinical Oncology, 2010, 136 : 1293 - 1294
  • [43] BRAF mutation predicts resistance to anti-EGFR monoclonal antibodies in wild-type KRAS metastatic colorectal cancer
    Mao, Chen
    Liao, Ru-Yan
    Chen, Qing
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2010, 136 (08) : 1293 - 1294
  • [44] Raise and decline of KRAS mutant clones in colorectal cancers (CRCs) treated with multiple rounds of anti-EGFR antibodies.
    Siravegna, Giulia
    Mussolin, Benedetta
    Buscarino, Michela
    Corti, Giorgio
    Crisafulli, Giovanni
    Ponzetti, Agostino
    Cremolini, Chiara
    Lamba, Simona
    Avallone, Antonio
    Rospo, Giuseppe
    Veronese, Silvio
    Budillon, Alfredo
    Montagut, Clara
    Racca, Patrizia
    Corcoran, Ryan Bruce
    Di Nicolantonio, Federica
    Loupakis, Fotios
    Siena, Salvatore
    Sartore-Bianchi, Andrea
    Bardelli, Alberto
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [45] Correction: Protein biomarkers predictive for response to anti-EGFR treatment in RAS wild-type metastatic colorectal carcinoma
    Astrid Lièvre
    Bérèngere Ouine
    Jim Canet
    Aurélie Cartier
    Yael Amar
    Wulfran Cacheux
    Odette Mariani
    Rosine Guimbaud
    Janick Selves
    Thierry Lecomte
    Serge Guyetant
    Ivan Bieche
    Frédérique Berger
    Leanne de Koning
    British Journal of Cancer, 2018, 119 : 387 - 387
  • [46] Plasma RAS dynamics and efficacy of anti-EGFR rechallenge in patients with RAS/BRAF wild-type metastatic colorectal cancer: REMARRY and PURSUIT trials
    Kagawa, Y.
    Kotani, D.
    Bando, H.
    Takahashi, N.
    Horita, Y.
    Kanazawa, A.
    Kato, T.
    Ando, K.
    Satake, H.
    Shinozaki, E.
    Sunakawa, Y.
    Takashima, A.
    Yamazaki, K.
    Yuki, S.
    Nakajima, H.
    Nakamura, Y.
    Wakabayashi, M.
    Taniguchi, H.
    Ohta, T.
    Yoshino, T.
    ANNALS OF ONCOLOGY, 2022, 33 : S244 - S244
  • [47] Withholding anti-EGFR, the impact on outcome in RAS wild-type metastatic colorectal tumors (WAIT or ACT trial).
    Palmieri, Lola-Jade
    Mineur, Laurent
    Tougeron, David
    Rousseau, Benoit
    Granger, Victoire
    Gornet, Jean-Marc
    Smith, Denis Michel
    Lievre, Astrid
    Galais, Marie-Pierre
    Doat, Solene
    Pernot, Simon
    Bignon, Anne Laure
    Metges, Jean-Philippe
    Baba-Hamed, Nabil
    Sefrioui, David
    Obled, Stephane
    Vitellius, Carole
    Bouche, Olivier
    Henriques, Julie
    Coriat, Romain
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [48] MicroRNAs and response to anti-EGFR therapy in metastatic colorectal cancer.
    Blanco-Calvo, Moises
    Haz-Conde, Mar
    Rodriguez-Rigueiro, Teresa
    Figueroa, Angelica
    Reboredo, Margarita
    Medina Villaamil, Vanessa
    Lorenzo-Patino, Maria J.
    Arnal, Francisco
    Anton-Aparicio, Luis
    Alonso-Jaudenes Curbera, Guillermo
    Valladares-Ayerbes, Manuel
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [49] Should Anti-EGFR Agents Be Used in Right-Sided RAS Wild-type Advanced Colorectal Cancer?
    Triest, Lars
    Debeuckelaere, C.
    Vandamme, T.
    Van Den Heuvel, B.
    Van Den Brande, J.
    Papadimitriou, K.
    Rasschaert, M.
    Prenen, H.
    Peeters, M.
    CURRENT COLORECTAL CANCER REPORTS, 2019, 15 (04) : 130 - 134
  • [50] KRAS mutation detection in endoscopic biopsies of colorectal carcinoma: validity for response to anti-EGFR therapy
    Carvalho, L.
    Alarcao, A.
    Couceiro, P.
    Reis Silva, M.
    D'Aguiar, M. J.
    Teixeira, L.
    Ferreira, T.
    Sousa, V.
    VIRCHOWS ARCHIV, 2011, 459 : S41 - S42
12345